+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 35 Pages
  • January 2021
  • GlobalData
  • ID: 1322613
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Nuo Therapeutics Inc (AURX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, through the regenerative capacity of the human body to initate natural healing. The company's flagship product Aurix System, is a biodynamic hematogel designed to harness a patient's innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including venous leg ulcer, diabetic foot ulcer and pressure ulcer. The company has its facilities in Nashville, Tennessee and Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Nuo Therapeutics Inc - Key Facts
  • Nuo Therapeutics Inc - Key Employees
  • Nuo Therapeutics Inc - Key Employee Biographies
  • Nuo Therapeutics Inc - Major Products and Services
  • Nuo Therapeutics Inc - History
  • Nuo Therapeutics Inc - Company Statement
  • Nuo Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Nuo Therapeutics Inc - Business Description
  • Nuo Therapeutics Inc - Corporate Strategy
  • Nuo Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Nuo Therapeutics Inc - Strengths
  • Nuo Therapeutics Inc - Weaknesses
  • Nuo Therapeutics Inc - Opportunities
  • Nuo Therapeutics Inc - Threats
  • Nuo Therapeutics Inc - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Nuo Therapeutics Inc, Recent Deals Summary

Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact
  • Disclaimer

List of Tables
  • Nuo Therapeutics Inc, Key Facts
  • Nuo Therapeutics Inc, Key Employees
  • Nuo Therapeutics Inc, Key Employee Biographies
  • Nuo Therapeutics Inc, Major Products and Services
  • Nuo Therapeutics Inc, History
  • Nuo Therapeutics Inc, Other Locations
  • Nuo Therapeutics Inc, Subsidiaries
  • Nuo Therapeutics Inc, Key Competitors
  • Nuo Therapeutics Inc, Ratios based on current share price
  • Nuo Therapeutics Inc, Annual Ratios
  • Nuo Therapeutics Inc, Interim Ratios
  • Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Nuo Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Nuo Therapeutics Inc, Performance Chart (2014 - 2018)
  • Nuo Therapeutics Inc, Ratio Charts
  • Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Nuo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021



Companies Mentioned

A selection of companies mentioned in this report includes:

  • Osiris Therapeutics Inc
  • MiMedx Group Inc
  • Derma Sciences Inc
  • Bioxytran Inc
  • ThermoGenesis Holdings Inc
  • Integra LifeSciences Holdings Corp
  • Organogenesis Inc
  • ConvaTec Inc.